Clinical trial
Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s…
NCT00251238 · VSM Geneesmiddelen b.v., Industry · Completed
Key facts
| NCT number | NCT00251238 |
|---|---|
| Title | Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon |
| Official title | Efficacy and Tolerability of Ginkgo Biloba Extract EGb 761® in Patients With Raynaud´s Phenomenon |
| Lead sponsor | VSM Geneesmiddelen b.v., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Raynaud Disease |
| Intervention type | Drug |
| Interventions | Ginkgo biloba extract EGb 761 |
| Enrollment | 41 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Nov 9, 2005 |
| Last update posted | May 22, 2017 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: